Journal Article Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel in patients with locally advanced uterine cervical cancer: The JACCRO GY-01 trial.

Umayahara, Kenji  ,  Takekuma, Munetaka  ,  Hirashima, Yasuyuki  ,  Shin-Ei, Noda  ,  Ohno, Tatsuya  ,  Miyagi, Etsuko  ,  Hirahara, Fumiki  ,  Hirata, Eiji  ,  Kondo, Eiji  ,  Tabata, Tsutomu  ,  Nagai, Yutaka  ,  Aoki, Yoichi  ,  Wakatuki, Masaru  ,  Takeuchi, Masahiro  ,  Toita, Takafumi  ,  Takeshima, Nobuhiro  ,  Takizawa, Ken

140 ( 2 )  , pp.253 - 258 , 2015-12 , Elsevier Inc
ISSN:0090-8258
Description
A multicenter phase II trial was conducted to assess the efficacy and toxicity of concurrent chemoradiotherapy (CCRT) with weekly cisplatin (CDDP) and paclitaxel (PTX) in patients with locally advanced uterine cervical cancer.

Number of accesses :  

Other information